Betacyanins Functionalized Selenium Nanoparticles Inhibit HepG2 Cells Growth Via Mitochondria-Mediated Pathway

Xiang-Yi Tang,Shu-Juan Yu,Xiao-Ming Guo,He Li,Ming-Shun Chen,Tao Zhang,Cai-Yu Lei,Zhen-Gang Zhao,He-Cheng Meng
DOI: https://doi.org/10.1016/j.jff.2021.104359
IF: 5.6
2021-01-01
Journal of Functional Foods
Abstract:Over the past few years, selenium nanoparticles (SeNPs)-mediated chemotherapy has aroused extensive attention for its low toxicity and high anti-tumor properties. However, the stability and anti-tumor properties of SeNPs require further improvement. In this study, betacyanin (Bc), a natural bioactive compound, was designed to decorate SeNPs with substantial anticancer efficacy. As revealed from the results, Bc-modified SeNPs (Bc@SeNPs) exhibited an average size of 133 nm and remained in a stable state for at least 1 month. Besides, the Bc@SeNPs exhibited a higher antioxidant activity and bioavailability compared with those of naked SeNPs. Moreover, Bc@SeNPs potentiated chemotherapy was demonstrated to exhibit superior in vitro anti-tumor efficacy against HepG2 hepatoma carcinoma cells, which could activate caspase cascade and induce mitochondriamediated apoptosis. Overall, this study developed a novel strategy to increase the added value of red beet, and it was proved that Bc-functionalized SeNPs can act as potential chemotherapeutic agents for cancer therapy.
What problem does this paper attempt to address?